These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33998995)

  • 1. Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development.
    Bhatia S; Rawal R; Sharma P; Singh T; Singh M; Singh V
    Curr Neuropharmacol; 2022; 20(4):675-692. PubMed ID: 33998995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer's Disease.
    Monsalvo-Maraver LÁ; Maya-López M; Rangel-López E; Túnez I; Tinkov AA; Skalny A; Ferrer B; Aschner M; Santamaría A
    CNS Neurol Disord Drug Targets; 2023; 22(7):1039-1056. PubMed ID: 35713133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.
    Fišar Z
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer's Disease: A Critical Review of New and Old Little Regarded Findings.
    Atlante A; Valenti D
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
    Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
    Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
    Gao J; Wang L; Gao C; Arakawa H; Perry G; Wang X
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165580. PubMed ID: 31678156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress.
    Dewanjee S; Chakraborty P; Bhattacharya H; Chacko L; Singh B; Chaudhary A; Javvaji K; Pradhan SR; Vallamkondu J; Dey A; Kalra RS; Jha NK; Jha SK; Reddy PH; Kandimalla R
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):134-157. PubMed ID: 36206930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
    Kolaj I; Imindu Liyanage S; Weaver DF
    Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.
    Sharma C; Kim S; Nam Y; Jung UJ; Kim SR
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
    Wang W; Zhao F; Ma X; Perry G; Zhu X
    Mol Neurodegener; 2020 May; 15(1):30. PubMed ID: 32471464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of Mitochondria in Alzheimer's Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells.
    Atlante A; Valenti D; Latina V; Amadoro G
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Signatures of Alzheimer's Disease.
    Sharma P; Sharma A; Fayaz F; Wakode S; Pottoo FH
    Curr Top Med Chem; 2020; 20(9):770-781. PubMed ID: 32108008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.